title: Drug-induced long QT syndrome and drug development.
authors.forename: J M
authors.initials: JM
authors.lastname: Ritter
mesh_terms: D004562:Electrocardiography / Q000379:methods; D006801:Humans; D008133:Long QT Syndrome / Q000139:chemically induced* / Q000235:genetics; D016171:Torsades de Pointes / Q000235:genetics
references.citation: Proc Natl Acad Sci U S A. 2000 Oct 24;97(22):12329-33
references.pmid: 11005845
references.citation: Br J Clin Pharmacol. 2008 Sep;66(3):352-65
references.pmid: 18782142
references.citation: Br J Clin Pharmacol. 2008 Sep;66(3):386-95
references.pmid: 18637888
references.citation: Br J Clin Pharmacol. 2008 Aug;66(2):169-72
references.pmid: 18717914
references.citation: J Am Coll Cardiol. 1997 May;29(6):1397-402
references.pmid: 9137241
references.citation: Br J Clin Pharmacol. 2008 Sep;66(3):411-3
references.pmid: 18637893
references.citation: Br J Clin Pharmacol. 2008 Sep;66(3):345-51
references.pmid: 18782141
references.citation: Circulation. 1996 Oct 15;94(8):1996-2012
references.pmid: 8873679
references.citation: N Engl J Med. 1989 Aug 10;321(6):406-12
references.pmid: 2473403
references.citation: Nature. 1995 Aug 24;376(6542):640
references.pmid: 7651510
references.citation: Nihon Yakurigaku Zasshi. 2003 Jun;121(6):377-83
references.pmid: 12835531
references.citation: Br J Clin Pharmacol. 2008 Sep;66(3):396-404
references.pmid: 18662287
references.citation: Br J Clin Pharmacol. 2008 Sep;66(3):366-74
references.pmid: 18492126
references.citation: Lancet. 1996 Jul 6;348(9019):7-12
references.pmid: 8691967
references.citation: Br J Clin Pharmacol. 2008 Sep;66(3):375-85
references.pmid: 18662288